🔎 Trials Near Me

Hjem › Blodcancer › Utah

Blodcancer kliniske forsøg i Utah

8 studier for Blodcancer søger deltagere på steder i Utah.

Byer i Utah

Officiel studietekst (engelsk)

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • Huntsman Cancer Institute - University of Utah Health, Salt Lake City
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT04996875

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of Utah, Salt Lake City
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 6. jul. 2026 · NCT01351545

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

  • Primary Children's Hospital, Salt Lake City
RekruttererObservationsstudie
Op til 30 år · Alle køn · Opdateret 18. jun. 2026 · NCT06579469

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 1. jun. 2026 · NCT05663502

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

  • Primary Children's Hospital, Salt Lake City
RekruttererFase 3
Alder 2 til 18 · Alle køn · Opdateret 5. maj 2026 · NCT05711667

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

  • University of Utah, Salt Lake City
RekruttererFase 1
Alder 13 og opefter · Alle køn · Opdateret 5. maj 2026 · NCT04771572

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 16. apr. 2026 · NCT03328078

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Primary Children's Hospital, Salt Lake City
RekruttererFase 1
Alder 1 til 21 · Alle køn · Opdateret 6. dec. 2024 · NCT05476770

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.